Verition Fund Management’s Elevance Health ELV Stock Holding History

Verition Fund Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-700	Closed	-$364K	–	3306
2024 Q3	$364K	Sell	700 -500	-42%	-$267K	﹤0.01%	2523
2024 Q2	$650K	Buy	1,200 +600	+100%	+$317K	﹤0.01%	1911
2024 Q1	$311K	Buy	+600	New	+$298K	﹤0.01%	2283
2023 Q1	–	Sell	-3,400	Closed	-$1.74M	–	2251
2022 Q4	$1.74M	Sell	3,400 -800	-19%	-$406K	0.03%	672
2022 Q3	$1.91M	Buy	+4,200	New	+$2.01M	0.02%	937
2022 Q2	–	Sell	-3,800	Closed	-$1.87M	–	2547
2022 Q1	$1.87M	Buy	3,800 +1,000	+36%	+$457K	0.02%	1025
2021 Q4	$1.3M	Buy	+2,800	New	+$1.18M	0.01%	1127
2017 Q1	–	Sell	-4,200	Closed	-$604K	–	1239
2016 Q4	$604K	Buy	+4,200	New	+$562K	0.05%	468

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Verition Fund Management's ELV Position: Q1 2026 in Review

Verition Fund Management increased its Elevance Health (ELV) stake by 1,637% in Q1 2026, buying an estimated $3.9M and bringing the position to 12,607 shares worth $3.69M. The position accounts for 0.02% of the portfolio, ranked #706.

Verition Fund Management first reported a position in ELV in Q3 2013 and has held it in 46 quarters since. The position peaked at $73.7M in Q4 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Verition Fund Management held 12,607 shares of Elevance Health worth $3.69M as of Q1 2026.
Verition Fund Management bought 11,881 Elevance Health shares in Q1 2026, an estimated $3.9M.
Elevance Health made up 0.02% of Verition Fund Management's portfolio in Q1 2026, its #706 holding.
Verition Fund Management first reported a position in Elevance Health in Q3 2013 and has held it in 46 quarters since.
Verition Fund Management's Elevance Health position peaked at $73.7M in Q4 2023.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.